Sabin-derived inactivated poliovirus vaccine shows comparable safety to conventional IPV in adult booster recipients
New polio booster vaccine shows similar safety to current one
This meta-analysis of 4 trials involving 70 to 340 adults found that Sabin-derived inactivated poliovirus vaccine (sIPV) has a safety profil…
A new polio booster vaccine appears just as safe as the standard one for adults, with no major differences in pain, fever, or other side eff…
Sabin-strain inactivated poliovirus vaccine provides immunogenicity comparable to Salk-strain inactivated poliovirus vaccine
Sabin Strain Vaccine Shows Comparable Protection Against Polio
This systematic review and meta-analysis of 4646 infants found that Sabin-strain inactivated poliovirus vaccine (sIPV) yields seroconversion…
New analysis shows the Sabin-strain vaccine provides similar protection against polio as the Salk-strain for infants, supporting global heal…
New 6-in-1 infant vaccine licensed but availability delayed until at least 2021
New six-in-one vaccine for infants receives regulatory approval
A new combination vaccine for infants targeting diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B has received licensure.
A new six-in-one vaccine for infants has received regulatory approval, but it won't be available for use until 2021 or later.